Stonnington Group, LLC Abiomed Inc Transaction History

Stonnington Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 20, 2022	BUY	$242.49 - $301.46 $169,743 - $211,022	700 Added 43.75%	2,300 $582,000
Q2 2022 Jul 08, 2022	BUY	$224.73 - $338.64 $359,568 - $541,824	1,600 New	1,600 $428,000
Q1 2022 Apr 12, 2022	SELL	$277.25 - $366.29 $2.16 Million - $2.86 Million	-7,800 Closed	0 $0
Q4 2021 Jan 12, 2022	BUY	$300.63 - $371.35 $1.56 Million - $1.93 Million	5,200 Added 200.0%	7,800 $2.49 Million
Q4 2021 Jan 12, 2022	BUY	$300.63 - $371.35 $60,126 - $74,270	200 Added 8.33%	2,600 $830,000
Q3 2021 Oct 12, 2021	BUY	$310.19 - $376.2 $31,019 - $37,620	100 Added 4.35%	2,400 $809,000
Q2 2021 Jul 09, 2021	BUY	$262.71 - $351.17 $604,233 - $807,691	2,300 New	2,300 $748,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonnington Group, LLC with notifications on news.